OpportunityTitle: Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immune Deficiency (SCID)
AdditionalInformationOnEligibility: Eligible Applicants    Eligible Organizations    &#239;&#191;&#189;Eligible applicants are State or Territorial Public Health Newborn Bloodspot Screening Programs.  Eligible applicants may apply either as: an individual organization, or as the lead member of a consortium of multiple State Public Health laboratories with an existing Newborn Bloodspot Screening program,  or in partnership with an organization from the following list:  Public nonprofit organizations; private nonprofit organizations; for profit organizations; small, minority, and women-owned businesses; universities; colleges; research institutions; hospitals; community-based organizations; faith-based organizations; federally recognized or state-recognized American Indian/Alaska Native tribal governments; American Indian/Alaska Native tribally designated organizations; Alaska Native health corporations; urban Indian health organizations; tribal epidemiology centers; state and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau); and political subdivisions of states (in consultation with states).        A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If  applying as a bona fide agent of a state or local government, a legal, binding agreement  from the state or local government as documentation of the status is required. Attach with &quot;Other Attachment Forms&quot; when submitting via www.grants.gov.    Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are not allowed.
Description: The purpose of this funding opportunity is to promote research in support of the implementation of first time newborn bloodspot screening programs for SCID and is targeted to programs which were not fully operational before January 2011.Objectives:&#239;&#191;&#189; To expand laboratory capacity for SCID newborn screening in the US by the funding of capital costs for purchases (such as laboratory equipment, reagents, etc) in order to implement SCID testing&#239;&#191;&#189; To increase the pool of laboratory scientists with knowledge and skill in conducting newborn screening for SCID&#239;&#191;&#189; To provide training for the public health community (e.g., laboratory scientists, healthcare providers, NBS program officials, primary care physicians) about NBS tests for SCID and to foster its integration into the standard of care for communities &#239;&#191;&#189; To encourage participation in collaborative ventures to explore data analysis and statistical algorithms that can improve the predictive values of primary SCID NBS tests Note: Awards are intended as seed funding, and applicants must demonstrate a commitment to secure and sustain funds from other sources for routine program operation beyond the project period.
GrantorContactEmailDescription: PGOTIM@cdc.gov
GrantorContactText: Centers for Disease Control and Prevention &lt;br/&gt;Procurement and Grants Office &lt;br/&gt;TIMS &lt;br/&gt;Phone 770-488-2700
CloseDateExplanation: Letter of Intent Due Date:  April 15, 2011  Application Due Date:  May 31, 2011